|
Colchicine Placebo Clinical Trials
3 actively recruiting trials across 1 location
Also known as: Colchicine-Placebo tablet
Pipeline
Phase 3: 3
Top Sponsors
- Population Health Research Institute1
- Montreal Heart Institute1
- Hamilton Health Sciences Corporation1
Indications
- Heart Disease3
- Atherosclerosis of Extremities1
- Diabete Type 21
- Cardiovascular Diseases1
- Diabetes1
Other2 trials
New Haven, Connecticut1 trial
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Yale School of Medicine
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.